Home » Topics » BioWorld Science, Endocrine/metabolic

BioWorld Science, Endocrine/metabolic
RSS

Hypolipidemic compounds reported by Aventis in recent patent

April 18, 2001

Maxia describes series useful in diabetes and hyperproliferative disorders

April 17, 2001

Pfizer's somatostatin antagonists enhance GH secretion

April 17, 2001

Phase III Oxygent trial shows benefit in reducing and avoiding blood transfusions

April 17, 2001

Phytopharm's P-57 well tolerated in first stage of proof-of-principle trial

April 12, 2001

U.S. patent covers altered peptide ligands, including NBI-6024, and use in diabetes Rx

April 12, 2001

Spiro compounds for eating or metabolic disorders disclosed by Banyu

April 11, 2001

Hemopure approved for the first time in South Africa

April 11, 2001

3-D structure of GR determined as part of Karo Bio and Abbott collaboration

April 11, 2001

NPY antagonists with selectivity for Y5 receptors and their use in eating disorders

April 10, 2001

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 9, 2026.
New York University identifies new analogues of mannose-6-phosphate
BioWorld Science
New York University has discovered new analogues of mannose-6-phosphate reported to be potentially useful for the treatment of memory impairment,...
ASCO 2026: Chinese biopharma arrives at ASCO with pivotal wins
BioWorld
If the 2026 American Society of Clinical Oncology (ASCO) annual meeting in Chicago from May 30 to June 3 demonstrated anything about the evolution of China’s...
News in brief
BioWorld Asia
BioWorld Asia briefs for June 9, 2026
Skape Bio unlocks GPCR targets with de novo-designed miniproteins
BioWorld
Modulating G protein-coupled receptors (GPCRs) is one of the major challenges in biomedicine. These are flexible proteins with small, deep binding pockets. The...